证券日报网讯2月11日，新天药业（002873）在互动平台回答投资者提问时表示，截至2026年2月10日， 公司股东人数为27992户。 ...

Group 1 - The core point of the article is that Chuhuan Technology (001336) reported a total of 9,933 shareholders as of January 30, 2026 [1]

证券日报网讯2月11日，悦心健康（002162）在互动平台回答投资者提问时表示，截至2月10日，股东总 户数48871户。 ...

证券日报网讯2月11日，五方光电（002962）在互动平台回答投资者提问时表示，公司主要从事精密光 学元器件的研发、生产和销售，目前主要产品为红外截止滤光片、生物识别滤光片、微棱镜等，核心技 术包括精密光学镀膜技术、TGV加工能力、冷加工能力、精密涂布技术、激光切割工艺、精密丝印工 艺、精密贴合工艺等。 ...

Core Viewpoint - The company is focusing on strategic products in EC, edge computing, and health management chips, leveraging its "chip + algorithm + AI" full-stack capabilities [1] Group 1: Product Development - The market introduction and scaling cycle of the company's EC chips differ from traditional consumer chips, requiring deep collaboration with terminal ecosystems for R&D and validation [1] - The EC chip has entered the global mainstream laptop supply chain and has achieved large-scale shipments [1] - The lightweight edge BMC management chip is steadily being introduced to customers in response to the growing demand in the edge computing and server markets [1] Group 2: Health Management - The health management chip and solutions are being advanced in collaboration with industry partners to construct a closed loop from precise measurement to health services [1] Group 3: Strategic Focus - The company will continue to focus on high-potential sectors by deepening joint innovation with core customers and accelerating the commercialization process through scenario-based solutions [1] - These strategic layouts are expected to provide the company with long-term and unique growth momentum [1]

Group 1 - The core viewpoint of the article is that Yahua Group (002497) has responded to investor inquiries regarding its capacity construction plans and progress, indicating that such information should be based on the company's official disclosures [1]

Core Viewpoint - The company, Boji Pharmaceutical, is experiencing a decline in net profit due to a decrease in overall gross margin influenced by intensified industry competition before the third quarter of 2025 [1] Group 1: Financial Performance - The company's net profit is expected to decline year-on-year due to a decrease in overall gross margin [1] - Management expense ratio and R&D expense ratio have both decreased before the third quarter of 2025 as a result of enhanced internal management and cost reduction efforts [1] Group 2: Strategic Focus - The company will continue to focus on its core business, primarily clinical operations, to enhance its core competitiveness [1] - The company aims to make every effort to improve operational performance [1]

Group 1 - The core point of the article is that Bailong Chuangyuan (605016) reported a total of 15,685 shareholders as of February 10, 2026 [1]

证券日报网讯2月11日，汇顶科技（603160）在互动平台回答投资者提问时表示，截至2026年2月10日， 公司的股东户数为72199户，股东人数随着交易的进行实时变化，请谨慎对待。 ...

Group 1 - The core point of the article is that as of February 10, 2026, the number of shareholders for Beifang Navigation (stock code: 600435) is approximately 164,100 [1]